Research Using the NACC Database

ACE Inhibitor, Angiotensin II Receptor Blockers, and ApoE4 on Alzheimer's

   Lead Investigator:    Wendy Qiu
   Institution      :    Boston University
   E-Mail           :
   Proposal ID      :    313

Publications: 1 Qiu WQ, Mwamburi M, Besser LM , Zhu H, Li H, Wallack M, Phillips L , Qiao L, Budson AE, Stern R, Kowall N Angiotensin Converting Enzyme Inhibitors and the Reduced Risk of Alzheimer's disease in the Absence of Apoliprotein E4 allele Journal Article J Alzheimers Dis,37:421-428,2013,PMC3873370
2 Wallack M, Zhu H, Mwamburi M, Phillips LE , Budson A, Kowall N, Stern R, Qiu WQ Apolipoprotein E Allele, Angiotensin-Converting Enzyme and its inhibitors, in the Development of Alzheimer's Disease Abstract Alzheimers Dement,9:P616-617,2013,

Proposal Description:
  • twitter icon
  • facebook icon

NACC is funded by the National Institute on Aging (UO1 AG016976) and located in the Department of Epidemiology at the University of Washington School of Public Health, Walter A. Kukull, Ph.D., Director. Copyright© 2010 University of Washington.